CBD Nutraceuticals Market Size, Trend & Growth Projections to 2034
Market size and growth
The global CBD nutraceuticals market generated USD 10.7 billion in 2024 and is projected to witness strong expansion over the forecast period. From 2025 to 2034, the market is expected to grow at a CAGR of 17.5%, reaching a forecast value of USD 53.1 billion by 2034. This rapid growth reflects increasing consumer acceptance of cannabidiol-based health products and the broader shift toward preventive healthcare and wellness-focused consumption.
Request for sample of this research report @ https://www.gminsights.com/requestsample/detail/13355
Rising interest in natural, plant-derived supplements and growing confidence in the therapeutic potential of CBD are accelerating market penetration across both developed and emerging economies. Continuous product innovation, improved extraction technologies, and wider retail availability are further supporting sustained market growth during the forecast timeline.
Key market drivers
One of the primary drivers of the CBD nutraceuticals market is growing awareness of CBD’s health benefits in managing chronic conditions and enhancing overall wellness. Consumers are increasingly seeking alternatives to conventional pharmaceuticals, particularly for pain, inflammation, stress, anxiety, and sleep-related disorders. CBD’s non-addictive profile and favorable safety perception are reinforcing its appeal among health-conscious populations. Additionally, the rising demand for cleanlabel, plant-based, and functional nutrition products is strengthening market adoption. Technological advancements, including AI-powered personalization tools, are improving consumer experiences by enabling tailored product recommendations. Favorable regulatory developments in key markets, coupled with increased investment in research and development, are also driving innovation and long-term market expansion.
Market segmentation
The CBD nutraceuticals market is segmented by product type and application. By product, the market includes CBD oils, tinctures, capsules, soft gels, gummies, and other formulations. CBD oils represent the leading product segment, generating USD 3 billion in 2023. Their dominance is attributed to high bioavailability, rapid absorption through sublingual administration, and ease of dosage control. Available in multiple concentrations, CBD oils cater to diverse therapeutic requirements and consumer preferences. By application, the market covers pain management, sleep disorders, mental health, stress reduction, and other health uses. Pain management accounted for the largest share of 35.5% in 2024, driven by rising cases of arthritis, fibromyalgia, migraines, and other chronic pain conditions.
Regional analysis
North America remains the dominant region in the global CBD nutraceuticals market, supported by high consumer awareness and a relatively favorable regulatory environment. The United States leads regional demand and is projected to generate USD 25.7 billion by 2034, growing at a CAGR of 17.5% during the forecast period. Increasing prevalence of chronic pain, anxiety, and sleep disorders is driving strong adoption of CBD nutraceuticals across the country. Europe is also witnessing steady growth, supported by rising wellness trends and gradual regulatory clarity. Meanwhile, Asia Pacific is
emerging as a high-growth region due to expanding middle-class populations, increasing health awareness, and growing acceptance of plant-based nutraceutical products.
Key players
The competitive landscape of the CBD nutraceuticals market is characterized by the presence of both established nutraceutical companies and specialized CBD-focused brands. Market participants are emphasizing product innovation, organic sourcing, and sustainable farming practices to differentiate their offerings. Strategic partnerships, mergers, and acquisitions are commonly used to expand product portfolios and geographic reach. Companies are also investing heavily in quality assurance, clinical research, and transparent labeling to build consumer trust and comply with evolving regulatory standards. As competition intensifies, brands that combine scientific validation, sustainability, and personalized consumer engagement are expected to strengthen their position in the global CBD nutraceuticals market.
Report Content
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic diseases and mental health disorders
3.2.1.2 Growing demand for plant-based and natural supplements
3.2.1.3 Innovations in product development and formulations
3.2.2 Industry pitfalls and challenges
3.2.2.1 High costs of CBD extraction and product development
3.2.2.2 Limited consumer education and misconceptions about CBD
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter's analysis
3.7 PESTEL analysis
About Global Market Insights Inc.
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
Contact Us:
Aashit Tiwari Corporate Sales, USA
Global Market Insights Inc.
Toll Free: 1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-750-8484
APAC: +65-3129-7718
Email: sales@gminsights.com